Receptos Inc (RCPT) financial statements (2021 and earlier)

Company profile

Business Address 3033 SCIENCE PARK ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:67270
Cash and cash equivalents45824
Short-term investments 46
Other undisclosed cash, cash equivalents, and short-term investments2140
Prepaid expense2 
Prepaid expense and other current assets1
Other undisclosed current assets2(0)
Total current assets:67670
Noncurrent Assets
Property, plant and equipment10
Other noncurrent assets2 
Prepaid expense and other noncurrent assets1
Total noncurrent assets:21
TOTAL ASSETS:67871
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2915
Accounts payable85
Accrued liabilities168
Employee-related liabilities42
Debt 1
Deferred revenue and credits 1
Total current liabilities:2916
Noncurrent Liabilities
Long-term debt and lease obligation 4
Long-term debt, excluding current maturities 4
Liabilities, other than long-term debt 0
Deferred revenue and credits 0
Total noncurrent liabilities: 4
Total liabilities:2920
Stockholders' equity
Stockholders' equity attributable to parent64951
Common stock00
Additional paid in capital860147
Accumulated other comprehensive income (loss)(0)0
Accumulated deficit(211)(96)
Total stockholders' equity:64951
TOTAL LIABILITIES AND EQUITY:67871

Income statement (P&L) ($ in millions)

12/31/2014
12/31/2013
Gross profit:65
Operating expenses(117)(53)
Operating loss:(112)(48)
Nonoperating income (expense)(2)0
Investment income, nonoperating00
Foreign currency transaction loss, before tax(3) 
Other nonoperating income (expense)0(0)
Interest and debt expense(1)(0)
Net loss attributable to parent:(115)(48)
Other undisclosed net loss available to common stockholders, basic (2)
Net loss available to common stockholders, diluted:(115)(50)

Comprehensive Income ($ in millions)

12/31/2014
12/31/2013
Net loss:(115)(48)
Comprehensive loss:(115)(48)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0
Comprehensive loss, net of tax, attributable to parent:(115)(48)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: